Key Influencer in the Personalized Cancer Treatment Market 2025: Surge In Cancer Prevalence Fuels Expansion Of Personalized Cancer Treatment Market Driver

What Is the Forecasted Market Size and Growth Rate for the Personalized Cancer Treatment Market?
In recent times, the personalized cancer treatment market has seen a swift expansion. The market which stood at $181.55 billion in 2024 is expected to elevate to $201.57 billion in 2025, growing at a compound annual growth rate (CAGR) of 11.0%. The substantial growth during the historic period is creditable to advancements in genomics and molecular biology, escalated incidence of cancer, the influx in the adoption of personalized medicine, amplified awareness about various cancer treatment options, and bettered technologies for cancer diagnosis and monitoring.

The market size for personalized cancer treatment is predicted to experience a substantial rise in the upcoming years, surging to $303.01 billion in 2029 with a compound annual growth rate (CAGR) of 10.7%. This anticipated rise in the forecast period can be credited to the proliferation of targeted therapies, the evolution of AI and machine learning in treatment planning, escalating investments into cancer research, the burgeoning demand for precise medicine, and the inception of novel biomarkers for tailor-made treatments. Some notable trends predicted in the forecast include the escalating employment of combination therapies, increased cohesion of digital health tools, the widening acceptance of liquid biopsy techniques, the broadening scope of immunotherapy options, and a reinforced focus on patient-centric care models.

What Factors Are Propelling the Expansion of the Personalized Cancer Treatment Market?
The escalating prevalence of cancer is anticipated to fuel the progression of the personalized cancer treatment market. The upsurge in cancer cases is primarily due to the growth in life expectancy, which corresponds to an increase in the aging population where the incidence of cancer is higher, coupled with heightened exposure to risk factors such as tobacco, alcohol, and obesity. Personalized cancer interventions ensure tailored and efficient procedures to manage various kinds of cancer and stages, thereby pushing investment and innovation in precision medicine, with the objective of enhancing patient outcomes via individualized treatment strategies. For example, the World Health Organization indicated in February 2024 that the global burden of cancer is likely to surge significantly, with a projected 77% increment in new cancer instances, hitting above 35 million by 2050 from 20 million in 2022. Consequently, the surge in cancer prevalence is steering the expansion of the personalized cancer treatment market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19135&type=smp

Which Businesses Are at the Forefront of Personalized Cancer Treatment Market Development?
Major companies operating in the personalized cancer treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma

What Are the Latest Innovations in the Personalized Cancer Treatment Market?
Major players in the market for personalized cancer treatments are prioritizing the development of innovative solutions such as AI-powered multimodal immune profile algorithmic tests, aimed at predicting how patients will respond to immunotherapy and enhancing personal treatment plans. These AI-powered tests examine a variety of data, including genomic, transcriptomic, and clinical biomarkers, to gauge the immune profile of a patient and predict their reaction to immunotherapy, subsequently aiding in patient stratification and guiding the administration of personalized cancer treatments. For example, Tempus AI, Inc., an American health tech firm, in July 2024 unveiled its AI-powered multimodal immune profile algorithmic test (IPS), its initial product in the immunotherapy diagnostic arena. The test, which is only available for research purposes, evaluates a wide array of immunotherapy-related biomarkers to create a score that forecasts how a patient might respond to immunotherapy, thereby boosting personalized cancer therapy. These AI-based diagnostic tools with a focus on immunotherapy amplify patient stratification and selection of treatment options in the field of oncology.

How Is the Personalized Cancer Treatment Market Segmented?
The personalized cancer treatmentmarket covered in this report is segmented -

1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type
2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types
4) By End-Users: Hospitals And Clinics, Research Institutes, Other End Users

Subsegments:
1) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Angiogenesis Inhibitors, Signal Transduction Inhibitors
2) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines, Monoclonal Antibodies For Immunotherapy
3) By Hormone Therapy: Anti-Estrogens, Aromatase Inhibitors, Progestins, LHRH Agonists
4) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Taxanes
5) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Brachytherapy, Radioimmunotherapy, Stereotactic Radiosurgery (SRS)
6) By Other Treatment Types: Gene Therapy, Stem Cell Transplantation, Metabolic Therapy, Nanomedicine

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/personalized-cancer-treatment-global-market-report

Where Is the Personalized Cancer Treatment Market Growth Most Prominent?
North America was the largest region in the personalized cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Personalized Cancer Treatment Global Market Report?

- Market Size Analysis: Analyze the Personalized Cancer Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Personalized Cancer Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Personalized Cancer Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Personalized Cancer Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19135

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.